{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-003829","form_type":"8-K","ticker":"QCLS","cik":"0001321834","company_name":"Q/C TECHNOLOGIES, INC.","filed_at":"2025-04-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.915607+00:00","generated_at":"2026-05-23T15:56:27.424670+00:00","sec_items":["5.08"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"TNF Pharmaceuticals sets 2025 Annual Meeting for May 20; proposal deadline April 18","bullets":["Annual Meeting will be held virtually on May 20, 2025 at 10:00 a.m. Eastern.","Deadline for Rule 14a-8 stockholder proposals is April 18, 2025, close of business.","Deadline for director nominations and universal proxy notices also April 18, 2025.","Meeting date changed by more than 30 days from 2024 anniversary, triggering new deadlines."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-003829","json":"https://secwatch.observer/filing/0001641172-25-003829.json","markdown":"https://secwatch.observer/filing/0001641172-25-003829.md","text":"https://secwatch.observer/filing/0001641172-25-003829.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321834/000164117225003829/0001641172-25-003829-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321834/000164117225003829/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T15:56:27.424670+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}